March 28, 2013
Japan’s Otsuka Pharmaceutical and Danish partner H. Lundbeck A/S said on March 26 that they have inked an agreement to jointly develop and commercialize Lu AE58054, an experimental Alzheimer’s disease (AD) treatment currently under development by Lundbeck. Under the deal,...read more